Chlebowski Rt

496 total citations
11 papers, 388 citations indexed

About

Chlebowski Rt is a scholar working on Oncology, Dermatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chlebowski Rt has authored 11 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 2 papers in Dermatology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chlebowski Rt's work include Cancer Treatment and Pharmacology (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Chemotherapy-related skin toxicity (2 papers). Chlebowski Rt is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Chemotherapy-related skin toxicity (2 papers). Chlebowski Rt collaborates with scholars based in United States. Chlebowski Rt's co-authors include Block Jb, Chan Kk, Mark Tong, Steven A. Akman, Martin Dietrich, David K Cundiff, Bateman, James K. Luce, Ralph D. Reynolds and Mitchell Ms and has published in prestigious journals such as PubMed.

In The Last Decade

Chlebowski Rt

11 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chlebowski Rt United States 7 109 87 75 61 60 11 388
Braimbridge Mv United Kingdom 7 44 0.4× 62 0.7× 48 0.6× 10 0.2× 29 0.5× 15 365
Jorge Delgado Israel 15 42 0.4× 132 1.5× 17 0.2× 112 1.8× 156 2.6× 36 603
CD Heidecke Germany 11 28 0.3× 55 0.6× 32 0.4× 15 0.2× 41 0.7× 28 402
V K Kapoor India 13 98 0.9× 89 1.0× 7 0.1× 24 0.4× 46 0.8× 31 544
Gajra Arya United States 11 10 0.1× 100 1.1× 39 0.5× 34 0.6× 44 0.7× 18 438
Sun-Sang Wang Taiwan 13 31 0.3× 130 1.5× 32 0.4× 270 4.4× 34 0.6× 28 683
Ulrike Bachmann Germany 11 38 0.3× 35 0.4× 9 0.1× 18 0.3× 169 2.8× 20 459
R. Wanitschke Germany 13 54 0.5× 273 3.1× 36 0.5× 9 0.1× 58 1.0× 36 653
A. Anderson United States 7 17 0.2× 60 0.7× 45 0.6× 9 0.1× 59 1.0× 17 383
Cheryl A. Woolsey United States 10 19 0.2× 70 0.8× 19 0.3× 15 0.2× 64 1.1× 14 359

Countries citing papers authored by Chlebowski Rt

Since Specialization
Citations

This map shows the geographic impact of Chlebowski Rt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chlebowski Rt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chlebowski Rt more than expected).

Fields of papers citing papers by Chlebowski Rt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chlebowski Rt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chlebowski Rt. The network helps show where Chlebowski Rt may publish in the future.

Co-authorship network of co-authors of Chlebowski Rt

This figure shows the co-authorship network connecting the top 25 collaborators of Chlebowski Rt. A scholar is included among the top collaborators of Chlebowski Rt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chlebowski Rt. Chlebowski Rt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Rt, Chlebowski, et al.. (1993). Factors influencing nurses' breast cancer control activity.. PubMed. 1(4). 307–14. 5 indexed citations
2.
Rt, Chlebowski, et al.. (1989). Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS.. PubMed. 84(10). 1288–93. 169 indexed citations
3.
Rt, Chlebowski, Martin Dietrich, Steven A. Akman, & Block Jb. (1985). Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.. PubMed. 69(5). 527–32. 46 indexed citations
4.
Rt, Chlebowski, et al.. (1984). Concomitant razoxane and doxorubicin treatment on a weekly schedule.. PubMed. 68(7-8). 1035–7. 2 indexed citations
5.
Rt, Chlebowski, et al.. (1984). Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results.. PubMed. 68(3). 487–91. 81 indexed citations
6.
Rt, Chlebowski, et al.. (1982). Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell line.. PubMed. 66(1). 121–5. 26 indexed citations
7.
Rt, Chlebowski, et al.. (1981). Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.. PubMed. 64(8-9). 981–4. 6 indexed citations
8.
Rt, Chlebowski, et al.. (1981). Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project.. PubMed. 41(11 Pt 1). 4399–403. 29 indexed citations
9.
Rt, Chlebowski, et al.. (1981). Frequency and treatment of primary hepatocellular carcinoma in Los Angeles.. PubMed. 27. 6–13. 4 indexed citations
10.
Kk, Chan, et al.. (1980). Metabolism of methotrexate in man after high and conventional doses.. PubMed. 28(3). 551–61. 15 indexed citations
11.
Rt, Chlebowski, et al.. (1980). Treatment of advanced gastric carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.. PubMed. 63(11-12). 1979–81. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026